{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:57:44Z","timestamp":1776380264334,"version":"3.51.2"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020380","name":"Jaseng Medical Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100020380","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Osteoarthritis (OA) is a major degenerative disease that affects the elderly. The global prevalence of OA is increasing annually. However, current treatments are unable to halt the progress of OA. At present, pharmacological treatments such as non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2) inhibitors control the pain; however, there may be side effects to these medications. We hypothesized that Cortex Eucommiae (CE; <jats:italic toggle=\"yes\">Eucommia ulmoides<\/jats:italic> Oliver) extract, which is used as a dietary supplement, may slow down or prevent OA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a protocol for a 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CE extract in subjects with mild OA. One-hundred subjects with mild OA will be recruited and randomly divided in a 1:1 ratio into 2 groups. One group will receive CE extract for 12 weeks and the other group will receive placebo for 12 weeks. Outcomes will be evaluated by using the visual analog scale (VAS), Korean-Western Ontario and McMaster Universities index (K-WOMAC), Korean-Short Form health survey-36 score (KSF-36), and laboratory test results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This clinical trial is expected to provide evidence of the efficacy and safety of CE extract as a treatment for mild OA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Clinical Trials.gov NCT03744611, registered on November 12, 2018, at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03744611\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000018318","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T13:52:51Z","timestamp":1576590771000},"page":"e18318","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of Cortex Eucommiae (Eucommia ulmoides Oliver) extract in subjects with mild osteoarthritis"],"prefix":"10.1097","volume":"98","author":[{"given":"Hyeon Yeong","family":"Ahn","sequence":"first","affiliation":[{"name":"Jaseng Spine and Joint Research Institute, Jaseng Medical Foundation, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Heung","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Korean Rehabilitation Medicine, College of Korean Medicine, Kyung Hee University, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwoo","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Acupuncture & Moxibustion, College of Korean Medicine, Kyung Hee University, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Acupuncture & Moxibustion, College of Korean Medicine, Dongguk University, Gyeongju, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Hyuk","family":"Ha","sequence":"additional","affiliation":[{"name":"Jaseng Spine and Joint Research Institute, Jaseng Medical Foundation, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,12]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/pmj.79.933.377","article-title":"Osteoarthritis","volume":"79","author":"Haq","year":"2003","journal-title":"Postgrad Med J"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","year":"2013","journal-title":"Lancet"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1142\/S0192415X79000039","article-title":"A contribution to our knowledge of Tu-chung \u2014 Eucommia Ulmoides","volume":"7","author":"Hu","year":"1979","journal-title":"Am J Chin Med"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1142\/S0192415X19500137","article-title":"Ethnobotany, phytochemistry and pharmacological properties of Eucommia ulmoides: a review","volume":"47","author":"Wang","year":"2019","journal-title":"Am J Chin Med"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1142\/S0192415X05002795","article-title":"Effect of Eucommia ulmoides on systolic blood pressure in the spontaneous hypertensive rat","volume":"33","author":"Lang","year":"2005","journal-title":"Am J Chin Med"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"5202908","DOI":"10.1155\/2016\/5202908","article-title":"Health-promoting properties of Eucommia ulmoides: a review","volume":"2016","author":"Hussain","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jep.2013.11.023","article-title":"Eucommia ulmoides Oliv.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine","volume":"151","author":"He","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3892\/etm.2013.1223","article-title":"Effects of an aqueous extract of Eucommia on articular cartilage in a rat model of osteoarthritis of the knee","volume":"6","author":"Lu","year":"2013","journal-title":"Exp Ther Med"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1142\/S0192415X12500115","article-title":"Eucommiae cortex inhibits TNF-\u03b1 and IL-6 through the suppression of caspase-1 in lipopolysaccharide-stimulated mouse peritoneal macrophages","volume":"40","author":"Kim","year":"2012","journal-title":"Am J Chin Med"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jep.2017.08.001","article-title":"Anti-inflammatory effect of Cortex Eucommiae via modulation of the toll-like receptor-4 pathway in lipopolysaccharide-stimulated RAW 264.7 macrophages","volume":"209","author":"Koh","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1248\/bpb.23.54","article-title":"The promoting effect of eucommiol from Eucommiae cortex on collagen synthesis","volume":"23","author":"Li","year":"2000","journal-title":"Biol Pharm Bull"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.curtheres.2009.05.004","article-title":"The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled trial","volume":"70","author":"Giordano","year":"2009","journal-title":"Curr Ther Res Clin Exp"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"9332","DOI":"10.1073\/pnas.1703856114","article-title":"Knee osteoarthritis has doubled in prevalence since the mid-20th century","volume":"114","author":"Wallace","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"R18-20230915","first-page":"83","article-title":"Picking a bone with WISP1 (CCN4): new strategies against degenerative joint disease","volume":"1","author":"Maiese","year":"2016","journal-title":"J Transl Sci"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-133-8-200010170-00016","article-title":"Osteoarthritis: new insights. Part 1: the disease and its risk factors","volume":"133","author":"Felson","year":"2000","journal-title":"Ann Intern Med"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines","volume":"43","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrrheum.2014.209","article-title":"TLR4 signalling in osteoarthritis\u2013finding targets for candidate DMOADs","volume":"11","author":"G\u00f3mez","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Front Biosci"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jep.2013.08.008","article-title":"A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint","volume":"149","author":"Park","year":"2013","journal-title":"J Ethnopharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:45:55Z","timestamp":1694821555000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018318"}},"subtitle":["Study protocol for a 12-week, multicenter, randomized, double-blind, placebo-controlled trial"],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":20,"journal-issue":{"issue":"50","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018318","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}